247 related articles for article (PubMed ID: 26950735)
21. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.
Kestin L; Grills I; Guckenberger M; Belderbos J; Hope AJ; Werner-Wasik M; Sonke JJ; Bissonnette JP; Xiao Y; Yan D;
Radiother Oncol; 2014 Mar; 110(3):499-504. PubMed ID: 24630539
[TBL] [Abstract][Full Text] [Related]
22. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
[TBL] [Abstract][Full Text] [Related]
23. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
[TBL] [Abstract][Full Text] [Related]
24. [Stereotactic body radiotherapy (SBRT) -- an overview under special consideration of SBRT and LITT in the therapy of liver metastases].
Ernst I; Lücking PS; Eickmeyer F; Beckers E; Roth A; Schneid S; Schwarzmaier HJ; Fiedler VU; Schulz U
Zentralbl Gynakol; 2006 Apr; 128(2):71-5. PubMed ID: 16673248
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
[TBL] [Abstract][Full Text] [Related]
26. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
27. Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?
Tanguturi SK; Niemierko A; Wo JY; Nguyen KN; Prichard H; Zhu AX; Wolfgang JA; Hong TS
Pract Radiat Oncol; 2017; 7(5):e323-e329. PubMed ID: 28341320
[TBL] [Abstract][Full Text] [Related]
28. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
[TBL] [Abstract][Full Text] [Related]
29. The Feasibility and Efficiency of Volumetric Modulated Arc Therapy-Based Breath Control Stereotactic Body Radiotherapy for Liver Tumors.
Qiu JJ; Ge W; Zhang L; Yao Y; Zheng X
Technol Cancer Res Treat; 2016 Oct; 15(5):674-82. PubMed ID: 26206766
[TBL] [Abstract][Full Text] [Related]
30. Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity.
Iwata H; Shibamoto Y; Hashizume C; Mori Y; Kobayashi T; Hayashi N; Kosaki K; Ishikawa T; Kuzuya T; Utsunomiya S
Technol Cancer Res Treat; 2010 Dec; 9(6):619-27. PubMed ID: 21070084
[TBL] [Abstract][Full Text] [Related]
31. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiation therapy for liver metastasis--case report and review of the literature. The role of patient preparation, treatment planning and its delivery.
Adamczyk M; Fundowicz M
J Cancer Res Ther; 2014; 10(3):519-25. PubMed ID: 25313731
[TBL] [Abstract][Full Text] [Related]
33. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
[TBL] [Abstract][Full Text] [Related]
34. Individualized image guided iso-NTCP based liver cancer SBRT.
Dawson LA; Eccles C; Craig T
Acta Oncol; 2006; 45(7):856-64. PubMed ID: 16982550
[TBL] [Abstract][Full Text] [Related]
35. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
Eriguchi T; Takeda A; Sanuki N; Oku Y; Aoki Y; Shigematsu N; Kunieda E
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1006-11. PubMed ID: 23102838
[TBL] [Abstract][Full Text] [Related]
36. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
[TBL] [Abstract][Full Text] [Related]
37. Adaptive liver stereotactic body radiation therapy: automated daily plan reoptimization prevents dose delivery degradation caused by anatomy deformations.
Leinders SM; Breedveld S; Méndez Romero A; Schaart D; Seppenwoolde Y; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1016-21. PubMed ID: 24071500
[TBL] [Abstract][Full Text] [Related]
38. [Follow-up after stereotactic body radiation therapy for liver tumours: A review of the literature and recommendations].
Janoray G; Mornex F
Cancer Radiother; 2015 Oct; 19(6-7):573-81. PubMed ID: 26341312
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
Folkert MR; Timmerman RD
Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
[TBL] [Abstract][Full Text] [Related]
40. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites.
Teh BS; Paulino AC; Lu HH; Chiu JK; Richardson S; Chiang S; Amato R; Butler EB; Bloch C
Technol Cancer Res Treat; 2007 Aug; 6(4):347-54. PubMed ID: 17668943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
